Skip Navigation
Home
Browse Guidelines
Expert Commentaries
Guideline Syntheses
Guideline Matrix
Guideline Resources
Compare Guidelines
Frequently Asked Questions
Submit Guidelines
About
myNGC
< Back

'thiazolidinedione'
Run an advanced search on this term

Search within:  

Sort results by:      



Filter results by:

1-18 of 18  
 
2.  
Optimal use recommendations for second- and third-line therapy for patients with type 2 diabetes. 2013 Jul. NGC:009997
Canadian Agency for Drugs and Technologies in Health - Nonprofit Organization. View all guidelines by the developer(s)
3.  
Management of type 2 diabetes mellitus. 1996 May (revised 2012 Sep). NGC:009416
University of Michigan Health System - Academic Institution. View all guidelines by the developer(s)

View associated Guideline Synthesis
5.  
The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. 2002 (revised 2012 Jun). NGC:009150
American Association for the Study of Liver Diseases - Nonprofit Research Organization; American College of Gastroenterology - Medical Specialty Society; American Gastroenterological Association Institute - Medical Specialty Society. View all guidelines by the developer(s)
6.  
Diagnosis and management of type 2 diabetes mellitus in adults. 1996 Mar (revised 2012 Apr). NGC:009095
Institute for Clinical Systems Improvement - Nonprofit Organization. View all guidelines by the developer(s)
7.  
Exenatide prolonged-release suspension for injection in combination with oral antidiabetic therapy for the treatment of type 2 diabetes. 2012 Feb. NGC:009078
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
8.  
9.  
Liraglutide for the treatment of type 2 diabetes mellitus. 2010 Oct. NGC:008295
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
10.  
11.  
Third-line therapy for patients with type 2 diabetes inadequately controlled with metformin and a sulfonylurea. 2010 Aug. NGC:008155
Canadian Agency for Drugs and Technologies in Health - Nonprofit Organization. View all guidelines by the developer(s)
12.  
VA/DoD clinical practice guideline for the management of diabetes mellitus. 1999 Dec (revised 2010 Aug). NGC:008116
Department of Defense - Federal Government Agency [U.S.]; Department of Veterans Affairs - Federal Government Agency [U.S.]; Veterans Health Administration - Federal Government Agency [U.S.]. View all guidelines by the developer(s)
13.  
Management of diabetes. A national clinical guideline. 2001 Nov (revised 2010 Mar). NGC:007892
Scottish Intercollegiate Guidelines Network - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
14.  
Diabetes management in the long term care setting. 2002 (revised 2010). NGC:009849
American Medical Directors Association - Professional Association. View all guidelines by the developer(s)
15.  
Polycystic ovary syndrome. 2009 Oct. NGC:007458
American College of Obstetricians and Gynecologists - Medical Specialty Society. View all guidelines by the developer(s)
16.  
Type 2 diabetes. The management of type 2 diabetes. 2004 Jun 17 (revised 2009 May). NGC:007460
National Clinical Guideline Centre for Acute and Chronic Conditions - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
17.  
Clinical practice guideline for type 2 diabetes. 2008 Jul 1 (reaffirmed 2013 Jun). NGC:009014
Basque Office for Health Technology Assessment, Osteba - State/Local Government Agency [Non-U.S.]; GuiaSalud - National Government Agency [Non-U.S.]; Ministry of Health (Spain) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
1-18 of 18